Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO)

CUSIP: 171126105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
6,039,027
Total 13F shares
25,012
Share change
-58,924
Total reported value
$16,032
Price per share
$0.64
Number of holders
4
Value change
-$41,031
Number of buys
1
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 171126105?
CUSIP 171126105 identifies CHRO - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO) as of Q4 2024

As of 31 Dec 2024, Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,012 shares. The largest 4 holders included TWO SIGMA SECURITIES, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Tower Research Capital LLC (TRC), and BANK OF AMERICA CORP /DE/. This page lists 4 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.